Diane Soli's Colleagues at Trevi Therapeutics
Diane Soli's Contact Details
HQ
203-304-2499
203-304-2499
Location
Company
Trevi Therapeutics
Trevi Therapeutics
Diane Soli's Company Details
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational oral therapy Haduvio™ (nalbuphine ER). Trevi is conducting a Phase 2b/3 clinical trial of Haduvio for the treatment of chronic pruritus associated with prurigo nodularis (PN) and a Phase 2 trial for chronic cough in patients with idiopathic pulmonary fibrosis (IPF). These conditions share a common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems, and both are areas of high unmet need. Founded in 2011, Trevi is headquartered in New Haven, CT.
Frequently Asked Questions about Diane Soli
Diane Soli currently works for Trevi Therapeutics, Inc..
Diane Soli's role at Trevi Therapeutics, Inc. is Director, Quality Assurance.
Diane Soli's email address is ***@trevitherapeutics.com. To view Diane Soli's full email address, please signup to ConnectPlex.
Diane Soli works in the Biotechnology industry.
Diane Soli's colleagues at Trevi Therapeutics are Joe Carrino, Katherine Takaki, Helena Brett-Smith, Kevin Fitzmaurice, Lisa Delfini, Dawn Newmin, Katie McManus and others.
Diane Soli's phone number is 203-304-2499